Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction

Journal of Immunology

Volumn 190, Issue 7, 2013, Pages 3189-3196

  Koni, Pandelakis A ^a   Bolduc, Anna ^a   Takezaki, Mayuko ^a   Ametani, Yutetsu ^a   Huang, Lei ^a   Lee, Jeffrey R ^a,b   Nutt, Stephen L ^c   Kamanaka, Masahito ^d   Flavell, Richard A ^d   Mellor, Andrew L ^a   Tsubata, Takeshi ^e   Shimoda, Michiko ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; PROGRAMMED DEATH 1 RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; INFLAMMATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTIGENS; ANTIGENS, CD40; AUTOCRINE COMMUNICATION; B-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; CYTOTOXICITY, IMMUNOLOGIC; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, TRANSGENIC; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 84875471692     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203364     Document Type: Article

References (55)

1. Elgueta, R., M. J. Benson, V. C. de Vries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229: 152-172.
2. Peters, A. L., L. L. Stunz, and G. A. Bishop. 2009. CD40 and autoimmunity: the dark side of a great activator. Semin. Immunol. 21: 293-300.
3. Sprague, D. L., J. M. Sowa, B. D. Elzey, and T. L. Ratliff. 2007. The role of platelet CD154 in the modulation in adaptive immunity. Immunol. Res. 39: 185-193.
4. Schneider, R., A. N. Mohebiany, I. Ifergan, D. Beauseigle, P. Duquette, A. Prat, and N. Arbour. 2011. B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients. J. Immunol. 187: 4119-4128.
5. Imadome, K., M. Shirakata, N. Shimizu, S. Nonoyama, and Y. Yamanashi. 2003. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc. Natl. Acad. Sci. USA 100: 7836-7840.
6. Grammer, A. C., M. C. Bergman, Y. Miura, K. Fujita, L. S. Davis, and P. E. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154: 4996-5010.
7. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97: 2063-2073.
8. Devi, B. S., S. Van Noordin, T. Krausz, and K. A. Davies. 1998. Peripheral blood lymphocytes in SLE - hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J. Autoimmun. 11: 471- 475.
9. Moses, A. V., S. E. Williams, J. G. Strussenberg, M. L. Heneveld, R. A. Ruhl, A. C. Bakke, G. C. Bagby, and J. A. Nelson. 1997. HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas. Nat. Med. 3: 1242-1249.
10. Clodi, K., Z. Asgary, S. Zhao, K. O. Kliche, F. Cabanillas, M. Andreeff, and A. Younes. 1998. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells. Br. J. Haematol. 103: 270-275.
11. Voorzanger-Rousselot, N., and J. Y. Blay. 2004. Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role. Leuk. Lymphoma 45: 1239-1245.
12. Fu, L., Y. C. Lin-Lee, L. V. Pham, A. Tamayo, L. Yoshimura, and R. J. Ford. 2006. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107: 4540-4548.
13. Pham, L. V., A. T. Tamayo, L. C. Yoshimura, Y. C. Lin-Lee, and R. J. Ford. 2005. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106: 3940-3947.
14. Higuchi, T., Y. Aiba, T. Nomura, J.Matsuda, K. Mochida, M. Suzuki, H. Kikutani, T. Honjo, K. Nishioka, and T. Tsubata. 2002. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J. Immunol. 168: 9-12.
15. Bolduc, A., E. Long, D. Stapler, M. Cascalho, T. Tsubata, P. A. Koni, and M. Shimoda. 2010. Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas. J. Immunol. 185: 220-230.
16. Kishi, Y., Y. Aiba, T. Higuchi, K. Furukawa, T. Tokuhisa, T. Takemori, and T. Tsubata. 2010. Augmented antibody response with premature germinal center regression in CD40L transgenic mice. J. Immunol. 185: 211-219.
17. Kawamura, T., T. Kanai, T. Dohi, K. Uraushihara, T. Totsuka, R. Iiyama, C. Taneda, M. Yamazaki, T. Nakamura, T. Higuchi, et al. 2004. Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J. Immunol. 172: 6388-6397.
18. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
19. Chen, J., M. Trounstine, F. W. Alt, F. Young, C. Kurahara, J. F. Loring, and D. Huszar. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5: 647-656.
20. Kallies, A., A. Xin, G. T. Belz, and S. L. Nutt. 2009. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31: 283-295.
21. Ahmadi, T., A. Flies, Y. Efebera, and D. H. Sherr. 2008. CD40 ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class IIbinding peptides. Immunology 124: 129-140.
22. Mathieu, M., N. Cotta-Grand, J. F. Daudelin, S. Boulet, R. Lapointe, and N. Labrecque. 2012. CD40-activated B cells can efficiently prime antigen-specific naive CD8+ T cells to generate effector but not memory T cells. PLoS One 7: e30139.
23. Quigley, M. F., V. D. Gonzalez, A. Granath, J. Andersson, and J. K. Sandberg. 2007. CXCR5+ CCR72 CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles. Eur. J. Immunol. 37: 3352-3362.
24. Rutishauser, R. L., G. A. Martins, S. Kalachikov, A. Chandele, I. A. Parish, E. Meffre, J. Jacob, K. Calame, and S. M. Kaech. 2009. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31: 296-308.
25. Surh, C. D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 29: 848-862.
26. Xiao, Z., M. F. Mescher, and S. C. Jameson. 2007. Detuning CD8 T cells: downregulation of CD8 expression, tetramer binding, and response during CTL activation. J. Exp. Med. 204: 2667-2677.
27. Terawaki, S., S. Chikuma, S. Shibayama, T. Hayashi, T. Yoshida, T. Okazaki, and T. Honjo. 2011. IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. J. Immunol. 186: 2772-2779.
28. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
29. Tajima, M., D. Wakita, D. Noguchi, K. Chamoto, Z. Yue, K. Fugo, H. Ishigame, Y. Iwakura, H. Kitamura, and T. Nishimura. 2008. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J. Exp. Med. 205: 1019-1027.
30. Khoruts, A., and J. M. Fraser. 2005. A causal link between lymphopenia and autoimmunity. Immunol. Lett. 98: 23-31.
31. Le Campion, A., M. C. Gagnerault, C. Auffray, C. Bécourt, M. Poitrasson-Rivière, E. Lallemand, B. Bienvenu, B. Martin, F. Lepault, and B. Lucas. 2009. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 114: 1784-1793.
32. Feng, T., L. Wang, T. R. Schoeb, C. O. Elson, and Y. Cong. 2010. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207: 1321-1332.
33. Hamilton, S. E., M. C. Wolkers, S. P. Schoenberger, and S. C. Jameson. 2006. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat. Immunol. 7: 475-481.
34. King, C., A. Ilic, K. Koelsch, and N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265-277.
35. Le Saout, C., S. Mennechet, N. Taylor, and J. Hernandez. 2008. Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions. Proc. Natl. Acad. Sci. USA 105: 19414-19419.
36. Liblau, R. S., F. S. Wong, L. T. Mars, and P. Santamaria. 2002. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17: 1-6.
37. Kang, Y. M., X. Zhang, U. G. Wagner, H. Yang, R. D. Beckenbaugh, P. J. Kurtin, J. J. Goronzy, and C. M. Weyand. 2002. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195: 1325-1336.
38. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
39. Wei, B., T. T. Su, H. Dalwadi, R. P. Stephan, D. Fujiwara, T. T. Huang, S. Brewer, L. Chen, M. Arditi, J. Borneman, et al. 2008. Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur. J. Immunol. 38: 3411-3425.
40. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
41. Mauri, C., and A. Bosma. 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30: 221-241.
42. Koschella, M., D. Voehringer, and H. Pircher. 2004. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells. J. Immunol. 172: 4804-4811.
43. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
44. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107: 14733-14738.
45. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
46. Sun, J., H. Dodd, E. K. Moser, R. Sharma, and T. J. Braciale. 2011. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12: 327-334.
47. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
48. Chikuma, S., S. Terawaki, T. Hayashi, R. Nabeshima, T. Yoshida, S. Shibayama, T. Okazaki, and T. Honjo. 2009. PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J. Immunol. 182: 6682-6689.
49. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
50. Akbar, A. N., and S. M. Henson. 2011. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat. Rev. Immunol. 11: 289-295.
51. Blair, P. A., K. A. Chavez-Rueda, J. G. Evans, M. J. Shlomchik, A. Eddaoudi, D. A. Isenberg, M. R. Ehrenstein, and C. Mauri. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182: 3492-3502.
52. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
53. Yoshizaki, A., T. Miyagaki, D. J. DiLillo, T. Matsushita, M. Horikawa, E. I. Kountikov, R. Spolski, J. C. Poe, W. J. Leonard, and T. F. Tedder. 2012. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491: 264-268.
54. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
55. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.